CKColleen M. Kennedy

Colleen M. Kennedy

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Colleen M. Kennedy has a total of 15 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Prevalence of vulvar and vaginal symptoms during pregnancy and the puerperium

    by Colleen M. Kennedy, Anne M. Turcea, Catherine S. Bradley

    Objective: To identify the prevalence of vulvar and vaginal symptoms during pregnancy and at 3 months post partum. Methods: A prospective, longitudinal, descriptive study of 103 pregnant women was undertaken in which a self‐administered questionnaire was completed at each trimester and 3 months post partum. Retrospective data was collected from 122 women, queried using similar tools, who comprised a nonpregnant control group. Descriptive and comparative statistics were employed. Results: The prevalence of vulvar burning, itching, pain, and vaginal discharge generally increased during pregnancy, and improved postpartum. Dyspareunia increased during pregnancy, but remained elevated post partum. Compared with the historical nonpregnant group (adjusted for age, marital status, education, and smoking), dyspareunia was reported less often in the first trimester ( P = 0.03) and more often post partum ( P < 0.01). Furthermore, reports of vulvar pain and vaginal discharge were significantly greater during the second and third trimesters. Conclusions: Vulvar and vaginal symptoms are common during pregnancy, and the prevalence of some, but not all, increase during gestation and decrease post partum.


  • Histopathology of recurrent mechanical fissure of the fourchette

    by Colleen M. Kennedy, Elizabeth Manion, Rudolph P. Galask, Jo Benda

    Click on the article title to read more.


    • 1 October 2008
      • Vol. 53  (10) , 781-4

    Erosive vulvar lichen planus: a cohort at risk for cancer?

    by Colleen M Kennedy, Lorna B Peterson, Rudolph P Galask

    To determine the occurrence of cancer, including vulvovaginal squamous cell carcinoma (SCC), among women after diagnosis of erosive vulvar lichen planus (LP). Retrospective review of 113 patients diagnosed with erosive vulvar LP over an 8-year period (average follow-up, 5 years). A diagnosis of cancer was made in 5 women after diagnosis of erosive vulvar LP. Of these, 1 had stage II vulvar SCC after treatment for stage IIB cervical cancer, and 2 with oral LP had subsequent diagnoses of oral or esophageal SCC. The remaining 2 cancer diagnoses included cervical adenocarcinoma in situ and rectal adenocarcinoma. Of 113 women with erosive vulvar LP, 1 had subsequent development of vulvar SCC. Estimating the risk of SCC among women with vulvar LP is difficult because of the low prevalence of each disorder. Additionally, given the age of the patient and multifocal involvement, association with human papillomavirus was likely. Rather, this cohort exemplifies the need for long-term evaluation in the management of vulvar LP.


  • New Approaches to External Genital Warts and Vulvar Intraepithelial Neoplasia

    by Colleen M. Kennedy, Lori A. Boardman

    Human papillomavirus is the most common sexually transmitted disease in the United States. For the majority of affected individuals, the virus remains subclinical. However, human papillomavirus infection may result in a broad spectrum of vulvar disease including genital warts, dysplasia, and invasive carcinoma. We review the evaluation and currently available therapies to assist in patient management.


    • 1 December 2007
      • Vol. 52  (12) , 1073-8

    Bladder and bowel symptoms among women with vulvar disease: are they universal?

    by Colleen M Kennedy, Ingrid E Nygaard, Catherine S Bradley, Rudolph P Galask

    To compare the prevalence of painful bladder syndrome, recurrent urinary tract infections, urinary leakage and irritable bowel syndrome between women with specific vulvar disorders and controls. Women with a primary diagnosis of vulvar intraepithelial neoplasia (dysplasia), vulvar vestibulitis (vestibulitis), contact vulvitis, atrophic vulvovaginitis, lichen simplex, lichen sclerosus and lichen planus, were compared to women presenting for annual examinations. As compared to controls, painful bladder syndrome was more prevalent among subjects with dysplasia, vestibulitis and contact vulvitis; a history of recurrent urinary tract infection was more prevalent among subjects with contact vulvitis; and urinary incontinence was less prevalent in subjects with lichen sclerosus. Irritable bowel syndrome was more prevalent among subjects with dysplasia, vestibulitis, lichen sclerosus, lichen planus and lichen simplex than controls. The prevalence of bladder and irritable bowel symptoms varies between vulvar disorders.


    • 1 November 2007
      • Vol. 52  (11) , 1057-8

    Prolonged vaginal and oral metronidazole for refractory Trichomonas vaginalis: a case report.

    by Sara Wood, Colleen M Kennedy, Rudolph P Galask

    Resistant Trichomonas vaginalis infection is typically treated with increased doses of oral metronidazole. Because of side effects that limit compliance, such treatment may be ineffective. A young woman had an 8-year history of T vaginalis that was refractory to multiple courses of metronidazole, tinidazole and intravaginal paromomycin. After microscopic examination confirmed trichomonads, she began an extended, 14-day course of combined oral and vaginal metronidazole. Six weeks later her symptoms were unchanged, but microscopy revealed fewer trichomonads. After a 5% acetic acid vaginal wash and dilute silver nitrate bladder instillation, she was given the same treatment for 21 days. Symptoms and trichomonads resolved, and 3 years later she remained asymptomatic. Prolonged vaginal and oral metronidazole, in combination with bladder and vaginal irrigation, should be considered in women with refractory T vaginalis.


    • 1 September 2007
      • Vol. 52  (9) , 852-4

    Prolapsing vaginal cyst: a case report.

    by Jessica Kresowik, Colleen M Kennedy, Susan Wing, Rudolph P Galask

    Miillerian duct cysts are remnants of the embryologic paramesonephric ducts. When remnants persist in the vagina, the patient may present with a cyst, which is usually asymptomatic and < 2.0 cm in diameter. A 33-year-old woman with a 4-year history of a cystic vaginal mass presented after the cyst rapidly enlarged and protruded. She reported discomfort with walking and increased vaginal pressure. The pedunculated, 8-cm cyst was surgically removed. Pathology revealed miillerian duct origin. Although millerian duct cysts are commonly described as small and located in the anterolateral vaginal wall, they should be included in the differential diagnosis of any large, protruding vaginal mass.


    • 1 January 2007
      • Vol. 52  (1) , 43-7

    Erosive vulvar lichen planus: retrospective review of characteristics and outcomes in 113 patients seen in a vulvar specialty clinic.

    by Colleen M Kennedy, Rudolph P Galask

    To describe the characteristics of women diagnosed with erosive vulvar lichen planus and the outcome of treatment utilized by a single practitioner. A retrospective review of 113 women with erosive vulvar lichen planus. Data were abstracted, including demographic information, medical history, vulvar symptom scores and treatments utilized. Dyspareunia and vulvar symptom scores before and following treatment were compared. The mean age at presentation for women with lichen planus was 50 years. Comorbid medical and vulvar conditions were commonly noted. Sexually active women noted an improvement in dyspareunia symptom score and report of pain-free intercourse. Other symptoms described by women at the first visit included: burning (n = 76), itching (69), pain (43) and abnormal discharge (71). While these symptoms were significantly reduced at the final visit (p < 0.05 for each), the presence of vulvovaginal symptoms commonly waxed and waned in this group. Overall, 33% had resolution of symptoms, and 19% had improvement without resolution of symptoms. This cohort extends our understanding of the characteristics of women with erosive vulvar lichen planus and emphasizes its characteristically chronic course. While the recognition of erosive vulvar lichen planus may prevent unnecessary medical and surgical procedures, continued efforts to improve treatment should be investigated.


  • Open Access

    Does Rubella Immunity Predict Measles Immunity? A Serosurvey of Pregnant Women

    by Colleen M. Kennedy, Barbara A. Burns, Kevin A. Ault

    Background. This study was undertaken to determine whether rubella immunity infers measles immunity in pregnant women. Methods. Stored serum samples were obtained from the Iowa State Hygienic Laboratory for evaluation of rubella and measles immunities with IgG enzyme‐linked immunosorbent assay. Results. Nine hundred serum samples were obtained for testing. The average age of the women at the time of antepartum serum collection was 28 (range, 14 to 44) years. Measles and rubella immunity were 88% and 98%, respectively; there was no effect of immunity status by age identified. Eighty eight percent of those with rubella immunity were also measles immune. There was no association between paired rubella and measles immunity identified, P < .0001. Discussion. Known rubella immunity did not infer measles immunity in our population. Thus, we recommend that pregnant women exposed to measles be tested and appropriately treated if they are found to be nonimmune.


  • Risk factors for painful bladder syndrome in women seeking gynecologic care

    by Colleen M. Kennedy, Catherine S. Bradley, Rudolph P. Galask, Ingrid E. Nygaard

    The aim of this cross-sectional study was to report risk factors for painful bladder syndrome in women. We surveyed 645 women presenting for care to general gynecology clinics and a vulvar specialty clinic using a standardized questionnaire and validated outcome measures. We used two definitions for painful bladder syndrome, based on the O‘Leary–Sant interstitial cystitis symptom and problem indices. Of those women surveyed, 29.5% met broader criteria and 8.5% met more restrictive criteria for painful bladder syndrome. After adjusting for confounders, bladder pain was significantly associated with current smoking, irritable bowel syndrome, and a generalized pain disorder. Tobacco use, the only modifiable association noted on multivariate analysis, has not been previously identified to our knowledge.